120 related articles for article (PubMed ID: 34686503)
1. The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis.
Li J; Liu Y; Zheng L
Ann Clin Lab Sci; 2021 Sep; 51(5):615-624. PubMed ID: 34686503
[TBL] [Abstract][Full Text] [Related]
2. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.
Vlecken DH; Bagowski CP
Zebrafish; 2009 Dec; 6(4):433-9. PubMed ID: 20047470
[TBL] [Abstract][Full Text] [Related]
3. Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.
Chen J; Ananthanarayanan B; Springer KS; Wolf KJ; Sheyman SM; Tran VD; Kumar S
Cancer Res; 2020 Jan; 80(1):69-78. PubMed ID: 31641031
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a novel family of serine/threonine kinases containing two N-terminal LIM motifs.
Okano I; Hiraoka J; Otera H; Nunoue K; Ohashi K; Iwashita S; Hirai M; Mizuno K
J Biol Chem; 1995 Dec; 270(52):31321-30. PubMed ID: 8537403
[TBL] [Abstract][Full Text] [Related]
5. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
6. Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase.
Sumi T; Matsumoto K; Nakamura T
J Biol Chem; 2001 Jan; 276(1):670-6. PubMed ID: 11018042
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of
Du X; Xia W; Fan W; Shen X; Wu H; Zhang H
Dis Markers; 2022; 2022():9365046. PubMed ID: 36118669
[No Abstract] [Full Text] [Related]
8. LIM kinase 2 is widely expressed in all tissues.
Acevedo K; Moussi N; Li R; Soo P; Bernard O
J Histochem Cytochem; 2006 May; 54(5):487-501. PubMed ID: 16399995
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
10. A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance.
Zhang Q; Luo Y; Qian B; Cao X; Xu C; Guo K; Wan R; Jiang Y; Wang T; Mei Z; Liu J; Lv C
Aging (Albany NY); 2024 May; 16(9):8000-8018. PubMed ID: 38709280
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Lu G; Zhou Y; Zhang C; Zhang Y
Front Genet; 2021; 12():671585. PubMed ID: 34149814
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence.
Huang JB; Wu YP; Lin YZ; Cai H; Chen SH; Sun XL; Li XD; Wei Y; Zheng QS; Xu N; Xue XY
J Cell Mol Med; 2020 Apr; 24(8):4698-4706. PubMed ID: 32168432
[TBL] [Abstract][Full Text] [Related]
13. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
14. The phosphorylation level of Cofilin-1 is related to the pathological subtypes of gastric cancer.
Kang X; Zhao C; Liu Y; Wang G
Medicine (Baltimore); 2022 Oct; 101(43):e31309. PubMed ID: 36316865
[TBL] [Abstract][Full Text] [Related]
15. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
16. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
[TBL] [Abstract][Full Text] [Related]
17. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators.
Manetti F
Med Res Rev; 2012 Sep; 32(5):968-98. PubMed ID: 22886629
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
19. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
20. Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition.
Sumi T; Hashigasako A; Matsumoto K; Nakamura T
Exp Cell Res; 2006 Apr; 312(7):1021-30. PubMed ID: 16455074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
